The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-4-methoxybenzyl-D-galactonoamidine ID: ALA3359122
PubChem CID: 137007055
Max Phase: Preclinical
Molecular Formula: C14H20N2O5
Molecular Weight: 296.32
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(C/N=C2\N[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)cc1
Standard InChI: InChI=1S/C14H20N2O5/c1-21-9-4-2-8(3-5-9)6-15-14-13(20)12(19)11(18)10(7-17)16-14/h2-5,10-13,17-20H,6-7H2,1H3,(H,15,16)/t10-,11+,12+,13-/m1/s1
Standard InChI Key: BUJSHVIRKFEOPO-MROQNXINSA-N
Molfile:
RDKit 2D
21 22 0 0 0 0 0 0 0 0999 V2000
13.7808 -9.3812 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7808 -10.1984 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4861 -10.6029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1914 -10.1984 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1914 -9.3812 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4861 -8.9685 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.9003 -8.9747 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.8985 -10.6080 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.4861 -11.4200 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.0737 -10.6080 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.0719 -8.9747 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0695 -8.1575 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.9027 -8.1575 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6116 -7.7510 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3214 -8.1662 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0298 -7.7603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0327 -6.9423 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3212 -6.5351 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6157 -6.9399 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7403 -6.5335 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.4481 -6.9420 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
5 7 2 0
4 8 1 6
3 9 1 1
2 10 1 1
1 11 1 1
11 12 1 0
7 13 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
17 20 1 0
20 21 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 296.32Molecular Weight (Monoisotopic): 296.1372AlogP: -1.36#Rotatable Bonds: 4Polar Surface Area: 114.54Molecular Species: NEUTRALHBA: 6HBD: 5#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 5#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.52CX Basic pKa: 7.30CX LogP: -1.56CX LogD: -1.81Aromatic Rings: 1Heavy Atoms: 21QED Weighted: 0.47Np Likeness Score: 0.67
References 1. Fan QH, Claunch KA, Striegler S.. (2014) Structure-activity relationship of highly potent galactonoamidine inhibitors toward β-galactosidase (Aspergillus oryzae)., 57 (21): [PMID:25295392 ] [10.1021/jm501111y ] 2. Pickens JB, Striegler S, Fan QH.. (2016) Arabinoamidine synthesis and its inhibition toward β-glucosidase (sweet almonds) in comparison to a library of galactonoamidines., 24 (16): [PMID:27298003 ] [10.1016/j.bmc.2016.04.069 ] 3. Pickens JB, Wang F, Striegler S.. (2017) Picomolar inhibition of β-galactosidase (bovine liver) attributed to loop closure., 25 (20): [PMID:28844803 ] [10.1016/j.bmc.2017.07.020 ]